DSwiss (DQWS) Receivables - Net (2016 - 2026)
DSwiss' (DQWS) quarterly Receivables - Net came in at $19232.0 in Q2 2026, down 65.31% year-over-year from $55443.0 in Q2 2025, and down 74.41% quarter-over-quarter from $75159.0 in Q1 2026.
Analysis
DSwiss (DQWS) Receivables - Net (2016 - 2026) Analysis & Trends
DSwiss (DQWS) has reported Receivables - Net for 11 consecutive years, with $19232.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Receivables - Net fell 65.31% year-over-year to $19232.0 in Q2 2026; TTM through Jun 2026 was $19232.0, a 65.31% decrease from a year earlier, with the FY2025 full-year figure at $17376.0, down 76.72% from the prior year.
- Receivables - Net was $19232.0 for Q2 2026 at DSwiss, down from $75159.0 in the prior quarter.
- Over five years, Receivables - Net peaked at $112864.0 in Q1 2022 and troughed at $17376.0 in Q4 2025.
- A 5-year average of $49720.9 and a median of $44112.0 in 2022 frame the typical range for Receivables - Net.
- Across the five-year window, Receivables - Net soared 8269.38% in 2022 and slumped 76.72% in 2025, its largest moves.
- Over 5 years, Receivables - Net stood at $17492.0 in 2022, then surged by 101.5% to $35247.0 in 2023, then surged by 111.79% to $74648.0 in 2024, then tumbled by 76.72% to $17376.0 in 2025, then advanced by 10.68% to $19232.0 in 2026.
- The last three Receivables - Net figures came in at $19232.0 (Q2 2026), $75159.0 (Q1 2026), and $17376.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.76 Bn | 69.72 Bn | 3.30 Bn |
| 2 | Kenvue | 35.95 Bn | 34.84 Bn | 2.30 Bn |
| 3 | Kimberly Clark | 34.91 Bn | 34.08 Bn | 1.60 Bn |
| 4 | Bath & Body Works | 3.94 Bn | 3.15 Bn | 692.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.94 Bn | 2.87 Bn | - |
| 6 | Perrigo | 2.07 Bn | 1.67 Bn | 313.90 Mn |
| 7 | Edgewell Personal Care | 1.33 Bn | 933.73 Mn | 242.50 Mn |
| 8 | Herbalife | 1.30 Bn | 935.57 Mn | 1.03 Bn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - |
| 10 | DSwiss | 6.21 Mn | 6.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19,232.00 |
| Mar 31, 2026 | 75,159.00 |
| Dec 31, 2025 | 17,376.00 |
| Sep 30, 2025 | 38,423.00 |
| Jun 30, 2025 | 55,443.00 |
| Mar 31, 2025 | 63,162.00 |
| Dec 31, 2024 | 74,648.00 |
| Sep 30, 2024 | 50,953.00 |
| Jun 30, 2024 | 38,222.00 |
| Mar 31, 2024 | 61,784.00 |
| Dec 31, 2023 | 35,247.00 |
| Sep 30, 2023 | 37,240.00 |
| Jun 30, 2023 | 87,081.00 |
| Mar 31, 2023 | 31,427.00 |
| Dec 31, 2022 | 17,492.00 |
| Sep 30, 2022 | 49,801.00 |
| Jun 30, 2022 | 29,422.00 |
| Mar 31, 2022 | 112,864.00 |
| Dec 31, 2021 | 209.00 |
| Sep 30, 2021 | 143,397.00 |